T2 Biosystems, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
T2 Biosystems, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • T2 Biosystems, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $6.27M, a 19.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.27M -$1.48M -19.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $6.66M -$1.43M -17.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.03M -$1.39M -16.5% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $7.4M -$1.35M -15.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $7.75M -$1.31M -14.5% Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $8.09M -$1.08M -11.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $8.42M -$1.05M -11.1% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $8.74M -$1.03M -10.5% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $9.06M -$994K -9.89% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $9.17M -$1.16M -11.3% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 $9.47M -$1.13M -10.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $9.77M -$1.27M -11.5% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $10.1M +$8.32M +481% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $10.3M +$8.26M +398% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $10.6M +$7.64M +258% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $11M +$7.67M +228% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $1.73M -$2.01M -53.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.08M -$2.03M -49.5% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $2.97M -$1.5M -33.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.36M Dec 31, 2019 10-K 2021-03-31
Q3 2019 $3.74M Sep 30, 2019 10-Q 2019-11-18
Q2 2019 $4.11M Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $4.46M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.